CN101057948A - 一种具有健脑益智,养心安神的中药制剂及其制备方法 - Google Patents
一种具有健脑益智,养心安神的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN101057948A CN101057948A CNA2006100767894A CN200610076789A CN101057948A CN 101057948 A CN101057948 A CN 101057948A CN A2006100767894 A CNA2006100767894 A CN A2006100767894A CN 200610076789 A CN200610076789 A CN 200610076789A CN 101057948 A CN101057948 A CN 101057948A
- Authority
- CN
- China
- Prior art keywords
- nourishing
- preparation
- brain
- radix
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 230000001737 promoting effect Effects 0.000 title description 2
- 210000004556 brain Anatomy 0.000 claims abstract description 38
- 239000003814 drug Substances 0.000 claims abstract description 28
- 239000000463 material Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 51
- 238000002156 mixing Methods 0.000 claims description 34
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 28
- 235000012239 silicon dioxide Nutrition 0.000 claims description 26
- 210000000582 semen Anatomy 0.000 claims description 24
- 229920002472 Starch Polymers 0.000 claims description 20
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 20
- 239000008107 starch Substances 0.000 claims description 20
- 235000019698 starch Nutrition 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 18
- 241000005787 Cistanche Species 0.000 claims description 16
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 16
- 239000002671 adjuvant Substances 0.000 claims description 16
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 16
- 229950005770 hyprolose Drugs 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 230000002936 tranquilizing effect Effects 0.000 claims description 16
- 241000242759 Actiniaria Species 0.000 claims description 15
- 241000208340 Araliaceae Species 0.000 claims description 15
- 241000489492 Arisaema Species 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 15
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 15
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 15
- 235000008434 ginseng Nutrition 0.000 claims description 15
- 235000019359 magnesium stearate Nutrition 0.000 claims description 14
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 14
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 14
- 238000000576 coating method Methods 0.000 claims description 13
- 239000002002 slurry Substances 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 10
- 210000000941 bile Anatomy 0.000 claims description 9
- 238000005242 forging Methods 0.000 claims description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 8
- 239000008101 lactose Substances 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 239000000741 silica gel Substances 0.000 claims description 5
- 229910002027 silica gel Inorganic materials 0.000 claims description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 241000209128 Bambusa Species 0.000 claims description 2
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 229960001375 lactose Drugs 0.000 claims description 2
- -1 mixing Substances 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 230000001256 tonic effect Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000336315 Cistanche salsa Species 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 9
- 206010022437 insomnia Diseases 0.000 description 9
- 238000005728 strengthening Methods 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 208000024827 Alzheimer disease Diseases 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000000314 lubricant Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000011800 void material Substances 0.000 description 6
- 208000007443 Neurasthenia Diseases 0.000 description 5
- 206010039966 Senile dementia Diseases 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 208000000044 Amnesia Diseases 0.000 description 4
- 208000031091 Amnestic disease Diseases 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 4
- 206010057315 Daydreaming Diseases 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 230000006986 amnesia Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000009747 swallowing Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020852 Hypertonia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 229920003081 Povidone K 30 Polymers 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000036995 brain health Effects 0.000 description 2
- 230000001713 cholinergic effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241001676635 Lepidorhombus whiffiagonis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002186 septum of brain Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
药材 | 药材量(g) | 药粉得量(g) | 出粉率(%) | 平均出粉率(%) |
赭石琥珀天竺黄 | 200.0200.0200.0266.0266.0266.0266.0266.0266.0 | 191.14189.78191.8250.39253.60252.35251.98251.64249.69 | 95.5794.8995.9094.1395.3494.8794.7394.6093.87 | 95.4594.7894.40 |
配方 | 主药(g) | 淀粉(g) | 糊精(g) | 乳糖(g) | 微晶纤维素(g) | 预胶化淀粉(g) | 结果 |
1234567891011 | 3030303030303030303030 | 20----1010--10- | -20---10--10-10 | --20---1010-55 | ---20---10105- | ----20-----5 | 可压性较差,片硬度小。可压性较差,片硬度小。可压性较差,片硬度小。可压性较差,片硬度小。可压性尚可可压性尚可,片硬度小可压性尚可,片硬度尚可可压性尚可可压性尚可可压性尚可可压性尚可 |
配方 | 主药(g) | 羟丙纤维素(g) | 磷酸氢钙(g) | 糊精(g) | 乳糖(g) | 结果 |
123 | 242424 | 888 | 7-- | -7- | --7 | 可压性稍好可压性一般可压性一般 |
编号 | 粘合剂 | 制粒效果 |
123 | 水10%淀粉浆10%PVP乙醇液 | 颗粒较松散,成型效果稍差,可压性较差所制软材软硬度适中;颗粒成型效果好颗粒较硬,成型效果一般 |
配方 | 主药(g) | 羟丙纤维素(g) | PVP(g) | 磷酸氢钙(g) | 粘合剂用量(ml) | 结果 |
123 | 242424 | 6.86.86.8 | 1.21.21.2 | 66.57 | 201510 | 可压性较好,片硬度合格可压性较好,片硬度稍小可压性较好,片硬度稍小 |
样品号 | 硬脂酸镁的用量(%) | 结果 | 休止角(°) |
123 | 00.51.0 | 颗粒流动性稍差颗粒流动性一般颗粒流动性较好 | 38.230.429.2 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610076789A CN101057948B (zh) | 2006-04-21 | 2006-04-21 | 一种具有健脑益智、养心安神的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610076789A CN101057948B (zh) | 2006-04-21 | 2006-04-21 | 一种具有健脑益智、养心安神的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101057948A true CN101057948A (zh) | 2007-10-24 |
CN101057948B CN101057948B (zh) | 2010-05-12 |
Family
ID=38864351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610076789A Active CN101057948B (zh) | 2006-04-21 | 2006-04-21 | 一种具有健脑益智、养心安神的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101057948B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103238706A (zh) * | 2013-04-25 | 2013-08-14 | 苏州谷力生物科技有限公司 | 提神醒脑益智茶 |
CN103479868A (zh) * | 2013-09-14 | 2014-01-01 | 郑世杰 | 一种治疗心虚胆怯型心律失常的中药及制备方法 |
CN108114219A (zh) * | 2017-12-27 | 2018-06-05 | 李佳峰 | 一种大脑排毒霜的制备方法 |
CN110478456A (zh) * | 2019-09-18 | 2019-11-22 | 上海医药集团青岛国风药业股份有限公司 | 一种健脑药物丸剂的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1748774A (zh) * | 2005-10-20 | 2006-03-22 | 北京阜康仁生物制药科技有限公司 | 补脑制剂及新的制备方法 |
-
2006
- 2006-04-21 CN CN200610076789A patent/CN101057948B/zh active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103238706A (zh) * | 2013-04-25 | 2013-08-14 | 苏州谷力生物科技有限公司 | 提神醒脑益智茶 |
CN103479868A (zh) * | 2013-09-14 | 2014-01-01 | 郑世杰 | 一种治疗心虚胆怯型心律失常的中药及制备方法 |
CN103479868B (zh) * | 2013-09-14 | 2015-04-22 | 郑世杰 | 一种治疗心虚胆怯型心律失常的中药及制备方法 |
CN108114219A (zh) * | 2017-12-27 | 2018-06-05 | 李佳峰 | 一种大脑排毒霜的制备方法 |
CN110478456A (zh) * | 2019-09-18 | 2019-11-22 | 上海医药集团青岛国风药业股份有限公司 | 一种健脑药物丸剂的制备方法 |
CN110478456B (zh) * | 2019-09-18 | 2022-02-22 | 上海医药集团青岛国风药业股份有限公司 | 一种健脑药物丸剂的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101057948B (zh) | 2010-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1915399A (zh) | 治疗高血压、高血脂、肥胖症及更年期综合症的制剂及其制备方法 | |
CN106361964A (zh) | 一种改善睡眠质量的中药组合物及其制备方法和应用 | |
CN100418548C (zh) | 一种药用组合物及其用途 | |
CN1840044A (zh) | 治疗失眠的药物及其制备方法 | |
CN1586475A (zh) | 维生素c口腔崩解片及其制备方法 | |
CN102416148B (zh) | 一种治疗抑郁症的药物和制备方法及其应用 | |
CN101057948A (zh) | 一种具有健脑益智,养心安神的中药制剂及其制备方法 | |
CN101049440A (zh) | 一种用于糖尿病的中药制剂及其制备方法 | |
CN1247202C (zh) | 薯蓣皂苷口腔崩解片及其制备方法 | |
CN105250989A (zh) | 一种用于抗疲劳的阿胶小肽组合物 | |
CN107693555A (zh) | 一种治疗糖尿病的药物及用途 | |
CN1709476A (zh) | 养心安眠胶囊 | |
CN1840087A (zh) | 治疗慢性疲劳综合症的精乌中药制剂及其制备方法 | |
CN1259095C (zh) | 一种安脑降压药物及其制备方法和应用 | |
CN114098085A (zh) | 一种具有辅助改善记忆功能的功能性食品组合物及用途 | |
CN1843437A (zh) | 一种治疗失眠症的药物组合物及其制备方法 | |
CN1250228C (zh) | 三七总皂苷口腔崩解片及其制备方法 | |
CN1270762C (zh) | 一种止咳平喘的药物及其制备方法 | |
CN100569265C (zh) | 一种糖脉康片及其制备方法 | |
CN1931279A (zh) | 治疗胆道感染的药物及其制备方法 | |
CN1247203C (zh) | 豆腐果苷口腔崩解片及其制备方法 | |
CN101057894A (zh) | 一种用于妇科的中药制剂及其制备方法 | |
CN1242766C (zh) | 一种预防和治疗慢性疲劳综合症的药物及其制备方法 | |
CN1672703A (zh) | 一种治疗过敏性鼻炎的药物辛芩片及其制备方法 | |
CN1634340A (zh) | 一种防治少儿呼吸系统疾病的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee after: Beijing Yinkeruisi Biological Medicine Research Co.,Ltd. Address before: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee before: Beijing Increase Biological Products Research Institute |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 100220 Beijing Changping District science and Technology Park, 79 battalion road 79, cloud Valley 24, 5 floor, 508 rooms. Patentee after: Beijing Ying Kerui Biological Medicine Research Co.,Ltd. Address before: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee before: Beijing Yinkeruisi Biological Medicine Research Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180906 Address after: 519000 room 312-60, 3 / F, aviation and new town planning exhibition hall, Jin Wan District, Zhuhai, Guangdong (central office area) Patentee after: Ying Kerui (Zhuhai) innovation Pharmaceutical Manufacturing Co.,Ltd. Address before: 100220 Beijing Changping District science and Technology Park, 79 battalion road 79, cloud Valley 24, 5 floor, 508 rooms. Patentee before: Beijing Ying Kerui Biological Medicine Research Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 519090 No. 201, 2nd Floor, South Side of Plant 3#, No. 362, Dingwan 7th Road, Sanzao Town, Jinwan District, Zhuhai City, Guangdong Province Patentee after: Yingkerui (Zhuhai Jinwan) Pharmaceutical Co.,Ltd. Address before: 519000 room 312-60, 3 / F, aviation and new town planning exhibition hall, Jin Wan District, Zhuhai, Guangdong (central office area) Patentee before: Ying Kerui (Zhuhai) innovation Pharmaceutical Manufacturing Co.,Ltd. |
|
CP03 | Change of name, title or address |